Case Reports
doi: 10.1111/j.1600-0420.2006.00764.x.
Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration
- PMID: 17083553
- DOI: 10.1111/j.1600-0420.2006.00764.x
Item in Clipboard
Case Reports
Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration
Acta Ophthalmol Scand.
2006 Dec.
Free article
No abstract available
Similar articles
-
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.Retina. 2006 Nov-Dec;26(9):988-93. doi: 10.1097/01.iae.0000247164.70376.91. Retina. 2006. PMID: 17151484 Clinical Trial.
-
Necessity of paracentesis before or after intravitreal injection of bevacizumab.Arch Ophthalmol. 2008 Sep;126(9):1314-5; author reply 1315. doi: 10.1001/archopht.126.9.1314. Arch Ophthalmol. 2008. PMID: 18779502 No abstract available.
-
Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.Ophthalmology. 2007 Jun;114(6):1179-85. doi: 10.1016/j.ophtha.2007.03.006. Ophthalmology. 2007. PMID: 17544776 Clinical Trial.
-
Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.Retina. 2009 Feb;29(2):133-48. doi: 10.1097/IAE.0b013e3181960a28. Retina. 2009. PMID: 19202423 Review.
-
[Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series].Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. doi: 10.1007/s00347-008-1702-6. Ophthalmologe. 2008. PMID: 18256841 Review. German.
Cited by
-
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005139. doi: 10.1002/14651858.CD005139.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2014 Aug 29;(8):CD005139. doi: 10.1002/14651858.CD005139.pub3. Update in: Cochrane Database Syst Rev. 2019 Mar 04;3:CD005139. doi: 10.1002/14651858.CD005139.pub4. PMID: 18425911 Free PMC article. Updated.
-
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.BMC Ophthalmol. 2007 Jun 7;7:10. doi: 10.1186/1471-2415-7-10. BMC Ophthalmol. 2007. PMID: 17555600 Free PMC article. Clinical Trial.
-
Bevacizumab: off-label use in ophthalmology.Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. doi: 10.4103/0301-4738.36474. Indian J Ophthalmol. 2007. PMID: 17951896 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
